/
ISPC
$2.79+$0.12 (+4.49%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$3.8M
1M shares
52-week range
$2.39 – $127.20
0% from low
Sector
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Exchange
NASDAQ
CS
Borrow rate
79.57%
Hard to borrow
Price (6 mo)
Loading chart…
Change$-5661.21
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.4M | $4.3M | $8.2M | $11.1M | $10.4M | $9.9M | $9.3M | $1.9M |
| Cost of revenue | $2.4M | $2.1M | $3.6M | $5.2M | $4.8M | $4.8M | $5.3M | $1.9M |
| Gross profit | $2.0M | $2.2M | $4.6M | $5.9M | $5.6M | $5.1M | $4.0M | $24.1K |
| Gross margin | 46.2% | 50.5% | 56.2% | 52.9% | 54.3% | 51.4% | 42.9% | 1.2% |
| R&D | $1.2M | $993.3K | $1.5M | $1.8M | $2.7M | $3.6M | $3.5M | $2.2M |
| Operating income | −$3.4M | −$3.9M | −$2.4M | −$5.9M | −$10.2M | −$11.2M | −$12.7M | −$9.0M |
| EBITDA | −$3.8M | −$2.5M | −$1.7M | −$5.9M | −$8.8M | −$8.8M | −$10.4M | −$8.7M |
| Net income | −$5.3M | −$4.7M | −$4.7M | −$9.0M | −$10.2M | −$11.1M | −$12.5M | −$10.5M |
| Net margin | -121.7% | -110.0% | -56.8% | -80.5% | -98.5% | -111.8% | -134.5% | -543.7% |
| EPS (diluted) | -4564.40 | -4039.60 | -5775.20 | -980.40 | -817.60 | -982.00 | -703.20 | -91.20 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $38M | $0.00 | $0.00–$0.00 | 0 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
iSpecimen Inc. Common Stock
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.
www.ispecimen.com- Employees
- 7
- IPO / List date
- Jun 17, 2021
- HQ
- WOBURN, MA
Held by traders on TradeandTell
No one on the platform currently holds ISPC.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in ISPC as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2026-04-28 | 1-for-40reverse |
| 2024-09-16 | 1-for-20reverse |
Recent trades on TradeandTell
No one on the platform has traded ISPC yet.
